Main Article Content
Erectile dysfunction, diabetes, sexual dysfunction, glycemic control, Saudi Arabia.
Background and Objective
Erectile dysfunction (ED) is a widespread clinical issue with many new cases diagnosed every year. The prevalence of ED in men with type 2 diabetes millitus (T2DM) ranges from 35–90%, depending on patient characteristics and the method used to diagnose it. There is inconsistent evidence about the association between ED and the degree of glycemic control in men with T2DM. Our main objective was to investigate the association between ED in patients with T2DM and poor glycemic control, as well as other factors.
Material and Methods
This is a cross-sectional study based on a self-administrated questionnaire. The study was conducted from July to September 2017at King Saud University-Medical City, Riyadh, Saudi Arabia. Participants in this study were older than 18-years-old. The data from the questionnaire were analyzed using the SPSS program (Armonk, NY, USA).
The prevalence of ED is 80.5%, while a severe degree is seen at 33%. There were several factors significantly associated with it, including age (p-value = 0.01), education level (p-value = 0.01), monthly income (p-value = 0.01), occupation status (p-value = 0.01), duration of diabetes (p-value = 0.01), type of treatment of diabetes (p-value = 0.01), and diabetes status (p-value = 0.01). Increasing age (above 60 years of age), duration, and uncontrolled diabetes were associated with a high risk of developing ED.
ED was highly prevalent in patients with T2DM and poor glycemic control, as well as advanced age and duration of diabetes: each was associated with increased risk of ED.
2. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994;151(1):54–61.
3. Nikoobakht M, Nasseh H, Pourkasmaee M. The relationship between lipid profile and erectile dysfunction. Int J Impot Res 2005;17(6):523–6.
4. Austoni E, Mirone V, Parazzini F, et al. Smoking as a risk factor for erectile dysfunction: data from the andrology prevention weeks 2001–2002: a study of the Italian Society of Andrology (SIA). Eur Urol 2005;48(5):810–8.
5. Montorsi P, Ravagnani PM, Galli S, et al. The artery size hypothesis: a macrovascular link between erectile dysfunction and coronary artery disease. Am J Cardiol. 2005;96(12):19–23.
6. Gazzaruso C, Giordanetti S, De Amici E, et al. Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation 2004;110(1):22–6.
7. Malavige LS, Levy JC. Erectile dysfunction in diabetes mellitus. J Sex Med 2009;6(5):1232–47.
8. AlMogbel TA. Erectile dysfunction and other sexual activity dysfunctions among Saudi type 2 diabetic patients. Int J Health Sci 2014;8(4):347.
9. Al-Nozha MM, Al-Maatouq MA, Al-Mazrou YY, et al. Diabetes mellitus in Saudi Arabia. Saudi Med J 2004;25(11):1603–10.
10. De Berardis G, Franciosi M, Belfiglio M, et al. Erectile dysfunction and quality of life in type 2 diabetic patients a serious problem too often overlooked. Diabetes care 2002;25(2):284–91.
11. Braun M, Wassmer G, Klotz T, Reifenrath B, et al.. Epidemiology of erectile dysfunction: results of theCologne Male Survey'. Int J Impot Res 2000;12(6):305–11.
12. Nicolosi A, Moreira ED, Shirai M, Tambi MIBM, Glasser DB. Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction. Urology 2003;61(1):201–6.
13. Balde N, Diallo A, Balde M, et al., editors. [Erectile dysfunction and diabetes in Conakry (Guinea): frequency and clinical characteristics from 187 diabetic patients]. Ann Endocrinol (Paris);2006.
14. El-Sakka AI, Tayeb KA. Erectile dysfunction risk factors in noninsulin dependent diabetic Saudi patients. J Urol 2003;169(3):1043–7.
15. Cho N, Ahn C, Park J, et al. Prevalence of erectile dysfunction in Korean men with type 2 diabetes mellitus. Diabet Med 2006;23(2):198–203.
16. Romeo JH, Seftel AD, Madhun ZT, Aron DC. Sexual function in men with diabetes type 2: association with glycemic control. J Urol 2000;163(3):788–91.
17. Giugliano F, Maiorino M, Bellastella G, Gicchino M, Giugliano D, Esposito K. Determinants of erectile dysfunction in type 2 diabetes. Int J Impot Res. 2010;22(3):204–9.
18. Ziaei-Rad M, Vahdaninia M, Montazeri A. Sexual dysfunctions in patients with diabetes: a study from Iran. Reprod Biol Endocrinol 2010;8(1):1.
19. Al-Turki YA. Erectile dysfunction among diabetic patients in Saudi Arabia: a hospital-based primary care study. J Family Community Med 2007;14(1):19.
20. Shamloul R, Ghanem H, Abou-Zeid A. Validity of the Arabic version of the sexual health inventory for men among Egyptians. Int J Impot Res 2004;16(5):452–5.
21. Rosen RC, Wing RR, Schneider S, et al. Erectile dysfunction in type 2 diabetic men: relationship to exercise fitness and cardiovascular risk factors in the Look AHEAD trial. J Sex Med 2009;6(5):1414–22.
22. Health NIo. National Heart, Lung and Blood Institute (1998) Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults: The evidence report. Obes Res 2006;6(2).
23. Chobanian AV, Bakris GL, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289(19):2560–71.
24. Panel NCEPNE. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002;106(25):3143.
25. Association AD. Standards of medical care in diabetes—2015: summary of revisions. Diabetes Care 2015;38(Supplement 1):S4-S.
26. Ziaei-Rad M, Vahdaninia M, Montazeri A. Sexual dysfunctions in patients with diabetes: a study from Iran. Reprod Biol Endocrinol 2010;8(1):50.
27. Selvin E, Burnett AL, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med 2007;120(2):151–7.
28. Al-Quwaidhi A, Pearce M, Critchley J, Sobngwi E, O'Flaherty M. Trends and future projections of the prevalence of adult obesity in Saudi Arabia, 1992-2022. East Mediterr Health J 2014;20(10):589.
29. Fareed M, Salam N, Khoja AT, Abdulrahman M. Life style related risk factors of type 2 diabetes mellitus and its increased prevalence in Saudi Arabia: A brief review. Health Sci 2017;6(3):125–32.
30. Thompson IM, Tangen CM, Goodman PJ, et al. Erectile dysfunction and subsequent cardiovascular disease. JAMA 2005;294(23):2996–3002.
31. Thethi TK, Asafu-Adjaye NO, Fonseca VA. Erectile dysfunction. Clin Diabetes 2005;23(3):105–13.
32. Khatib FA, Jarrah NS, Shegem NS, Bateiha AM, Abu-Ali RM, Ajlouni KM. Sexual dysfunction among Jordanian men with diabetes. Saudi Med J 2006;27(3):351.
33. Viera AJ, Clenney TL, Shenenberger DW, Green GF. Newer pharmacologic alternatives for erectile dysfunction. Am Fam Physician 1999;60(4):1159–66, 69, 72.
34. Al Helali NS, Abolfotouh MA, Ghanem HM. Pattern of erectile dysfunction in Jeddah city. Saudi Med J 2001;22(1):34–8.
35. Lu CC, Jiann BP, Sun CC, et al. Association of glycemic control with risk of erectile dysfunction in men with type 2 diabetes. J Sex Med 2009;6(6):1719–28.
36. McCulloch D, Campbell I, Wu F, Prescott R, Clarke B. The prevalence of diabetic impotence. Diabetologia 1980;18(4):279–83.
37. Mofid A, Seyedalinaghi S, Zandieh S, Yazdani T, Jam S. Prevalence and risk factors of erectile dysfunction in Iranian diabetic men. Acta Med Iran 2009;47(4):309–14.
38. Al‐Hunayan A, Al‐Mutar M, Kehinde EO, et al. The prevalence and predictors of erectile dysfunction in men with newly diagnosed with type 2 diabetes mellitus. BJU Int 2007;99(1):130–4.
39. Zheng H, Fan W, Li G, Tam T. Predictors for erectile dysfunction among diabetics. Diabetes Res Clin Pract 2006;71(3):313–9.
40. Wing RR, Rosen RC, Fava JL, et al. Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the Look AHEAD trial. J Sex Med 2010;7(1pt1):156–65.